Trademark: SCT BIO 2289513
Word
SCT BIO
ID
2289513
Trademark Type
Fancy, Figurative
Status
Protected: Registered/protected
Application Date
14 April 2022
Registration Date
14 April 2022
Renewal Date
14 April 2032
Owner(s)
Service
Davies Collison Cave Pty Ltd
Goods and Services:
Class 39:
Packaging services in the nature of applications of labels to cell therapy materials; storage and distribution of cell therapy materials.
Packaging services in the nature of applications of labels to cell therapy materials; storage and distribution of cell therapy materials.
Class 40:
Manufacture of cell therapy materials to the order and specification of others including filling; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies to the order and specification of others.
Manufacture of cell therapy materials to the order and specification of others including filling; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies to the order and specification of others.
Class 42:
Pharmaceutical research and development, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; scientific research and development, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; consultation in the field of pharmaceutical research and development, namely for cell therapy material materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; product research and development, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; biological materials testing services and biological laboratory services, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; contract research services in the field of cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies.
Pharmaceutical research and development, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; scientific research and development, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; consultation in the field of pharmaceutical research and development, namely for cell therapy material materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; product research and development, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; biological materials testing services and biological laboratory services, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; contract research services in the field of cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies.